Hot topics in infection and immunity in children II:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York, NY
Springer
2005
|
| Schriftenreihe: | Advances in experimental medicine and biology
568 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Published in association with the British Paediatric Allergy, Immunity and Infection Group (BPAIIG), the European Society for Infectious Diseases (ESPID), and the Department of Paediatrics, University of Oxford. -- "This book is based on the course "Infection and Immunity in Children 2004" which was held at Keble College Oxford, UK in June 2004. This is the second book in this series covering topics in infection and immunity during childhood"--P. v. Includes bibliographical references and index |
| Beschreibung: | XIX, 234 S. Ill., graph. Darst., Kt. 26 cm |
| ISBN: | 0387253416 9780387253411 |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV020867060 | ||
| 003 | DE-604 | ||
| 005 | 20070328 | ||
| 007 | t | ||
| 008 | 051114s2005 xxuabd| |||| 10||| eng d | ||
| 010 | |a 2005923474 | ||
| 020 | |a 0387253416 |9 0-387-25341-6 | ||
| 020 | |a 9780387253411 |9 978-0-387-25341-1 | ||
| 035 | |a (OCoLC)318301146 | ||
| 035 | |a (DE-599)BVBBV020867060 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-12 |a DE-355 | ||
| 050 | 0 | |a RJ401 | |
| 082 | 0 | |a 570 | |
| 084 | |a YD 1824 |0 (DE-625)153284:13153 |2 rvk | ||
| 245 | 1 | 0 | |a Hot topics in infection and immunity in children II |c ed. by Andrew J. Pollard ... |
| 264 | 1 | |a New York, NY |b Springer |c 2005 | |
| 300 | |a XIX, 234 S. |b Ill., graph. Darst., Kt. |c 26 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Advances in experimental medicine and biology |v 568 | |
| 500 | |a Published in association with the British Paediatric Allergy, Immunity and Infection Group (BPAIIG), the European Society for Infectious Diseases (ESPID), and the Department of Paediatrics, University of Oxford. -- "This book is based on the course "Infection and Immunity in Children 2004" which was held at Keble College Oxford, UK in June 2004. This is the second book in this series covering topics in infection and immunity during childhood"--P. v. | ||
| 500 | |a Includes bibliographical references and index | ||
| 650 | 4 | |a Kind | |
| 650 | 4 | |a Infection in children | |
| 650 | 4 | |a Children |x Diseases |x Immunological aspects | |
| 650 | 4 | |a Communicable diseases in children | |
| 650 | 4 | |a Infection |x drug therapy |x Child | |
| 650 | 4 | |a Infection |x immunology |x Child | |
| 650 | 4 | |a Bacterial Infections |x drug therapy |x Child | |
| 650 | 4 | |a Bacterial Infections |x immunology |x Child | |
| 650 | 4 | |a Virus Diseases |x drug therapy |x Child | |
| 650 | 4 | |a Virus Diseases |x immunology |x Child | |
| 650 | 0 | 7 | |a Infektionskrankheit |0 (DE-588)4026879-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Antimikrobieller Wirkstoff |0 (DE-588)4142688-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kind |0 (DE-588)4030550-8 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Kind |0 (DE-588)4030550-8 |D s |
| 689 | 0 | 1 | |a Infektionskrankheit |0 (DE-588)4026879-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Kind |0 (DE-588)4030550-8 |D s |
| 689 | 1 | 1 | |a Infektionskrankheit |0 (DE-588)4026879-2 |D s |
| 689 | 1 | 2 | |a Antimikrobieller Wirkstoff |0 (DE-588)4142688-5 |D s |
| 689 | 1 | |C b |5 DE-604 | |
| 700 | 1 | |a Pollard, Andrew J. |e Sonstige |4 oth | |
| 830 | 0 | |a Advances in experimental medicine and biology |v 568 |w (DE-604)BV000003102 |9 568 | |
| 856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014188871&sequence=000009&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-014188871 | ||
Datensatz im Suchindex
| _version_ | 1804134590842929152 |
|---|---|
| adam_text | Contents
Contributing Authors
1.
Necrotizing Encephalopathy
Sarah S. Long
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
4.5.
References
2.
Sophie Hambleton and Ann M. An/in
1.
2.
3.
3.1.
3.2.
3.3.
3.3.1.
3.3.2.
3.3.3.
4.
4.1.
4.2.
4.3.
5.
References
3.
Upton D. Allen
1.
2.
Contents
2.1.
2.2. Model
3. EBV-Related
3.1.
3.2.
3.3.
3.4.
4.
4.1. Serologie
4.2.
5.
5.1.
5.1.1.
5.1.2.
5.1.3.
5.1.4.
• 5.2.
5.3.
5.3.1.
5.3.2.
6.
6.1.
6.2.
6.3.
6.4.
6.5.
7.
References
4.
Tract Infection
Caroline
1.
2.
2.1.
2.1.1.
2.1.2.
2.2.
2.2.1.
2.2.2.
2.3.
2.3.1.
2.3.2.
2.4.
2.5.
2.6.
2.7.
3.
3.1.
Contents xi
3.2.
3.3.
3.4.
4.
4.1.
4.2.
5.
5.1.
5.2.
6.
6.1.
6.2.
6.3.
6.4.
References
5.
to Clinical Presentation
Johan Bylund,
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
and Resolution of Inflammation
5.
5.1.
5.2.
5.3.
5.4.
References
6.
Capucine
1.
2.
2.1.
2.2.
2.3.
2.4.
2.5. IL-12Rßl
2.6.
2.7.
2.8.
x¡¡
3.
3.1.
3.2.
3.3.
4.
Acknowledgments
References
7.
Sarah S. Long
1.
2.
2.1.
2.2.
2.3.
3.
3.1.
and Cervical Adenopathy
3.1.1.
3.1.2.
3.1.3.
3.2.
3.2.1.
3.2.2.
3.2.3.
3.2.4.
3.3.
3.3.1.
3.3.2.
3.3.3.
3.3.4.
3.4.
3.4.1.
3.4.2.
3.4.3.
3.4.4.
3.5.
3.5.1.
3.5.2.
3.5.3.
3.5.4.
4.
References
8.
Stephen Sze Shing Teo and
1.
2.
Contents xiii
2.1.
3.
3.1.
3.2.
4.
4.1.
4.1.1.
4.1.2.
4.2.
4.2.1.
4.2.2.
4.3.
4.4.
4.5.
4.5.1.
4.5.2.
4.5.3.
4.5.4.
4.5.5.
5.
5.1.
5.2.
5.3.
5.3.1.
5.3.2.
6.
6.1.
6.1.1.
6.1.2.
6.1.3.
and
6.2.
6.3.
6.4.
6.4.1.
6.4.2.
6.4.3.
7.
8.
References
9.
Peter J.
Loukas,
1.
2.
3.
4.
Promise for Developing Anthelminthic Vaccines
Contents
4.1.
4.2.
5.
Acknowledgments
References
10.
David A. Warrell
1.
2.
2.1.
2.2.
2.3.
globulin against EBLV?
2.4.
the United Kingdom?
3.
4.
5.
6.
7.
8.
8.1.
8.2.
8.3.
9.
10.
References
11.
Myron M.
1.
2.
3.
3.1.
3.2.
Chronic Typhoid Carriers
3.3.
3.3.1.
3.3.2.
3.3.3. Vi
3.4.
3.5. Vi
4.
References
Contents xv
12. Dexamethasone in
Bacterial Meningitis in Developing Countries:
Is it Beneficial?
Elizabeth Molyneux
1
2.
3.
4.
4.1.
5.
in Developing Countries
5.1.
5.1.1.
6.
7.
8.
and Placebo Group?
9.
References
13.
Therapy of Bacterial Meningitis in
Industrialised Countries?
Peter Mclntyre
1.
2.
3.
3.1.
3.1.1.
3.1.2.
3.1.3.
3.2.
3.2.1.
3.2.2.
3.2.3.
3.3.
3.3.1.
3.2.2.
3.4.
Sydney
3.4.1.
3.4.2.
4.
5.
References
xvi
14.
Tom Connell and Nigel Curtis
1.
2.
2.1.
2.2.
2.3.
2.4.
2.5.
3.
4.
4.1.
4.2.
5.
6.
6.1.
6.2.
6.3.
7.
7.1.
7.2.
7.3.
Acknowledgments
References
15.
Serogroup
Dominic F. Kelly and Rino Rappuoli
Abstract
1.
2.
3.
4.
References
Index
Contents
Contributing Authors
1.
Necrotizing Encephalopathy
Sarah S. Long
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
4.5.
References
2.
Sophie Hambleton and Ann M. An/in
1.
2.
3.
3.1.
3.2.
3.3.
3.3.1.
3.3.2.
3.3.3.
4.
4.1.
4.2.
4.3.
5.
References
3.
Upton D. Allen
1.
2.
Contents
2.1.
2.2. Model
3. EBV-Related
3.1.
3.2.
3.3.
3.4.
4.
4.1. Serologie
4.2.
5.
5.1.
5.1.1.
5.1.2.
5.1.3.
5.1.4.
• 5.2.
5.3.
5.3.1.
5.3.2.
6.
6.1.
6.2.
6.3.
6.4.
6.5.
7.
References
4.
Tract Infection
Caroline
1.
2.
2.1.
2.1.1.
2.1.2.
2.2.
2.2.1.
2.2.2.
2.3.
2.3.1.
2.3.2.
2.4.
2.5.
2.6.
2.7.
3.
3.1.
Contents xi
3.2.
3.3.
3.4.
4.
4.1.
4.2.
5.
5.1.
5.2.
6.
6.1.
6.2.
6.3.
6.4.
References
5.
to Clinical Presentation
Johan Bylund,
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
and Resolution of Inflammation
5.
5.1.
5.2.
5.3.
5.4.
References
6.
Capucine
1.
2.
2.1.
2.2.
2.3.
2.4.
2.5. IL-12Rßl
2.6.
2.7.
2.8.
x¡¡
3.
3.1.
3.2.
3.3.
4.
Acknowledgments
References
7.
Sarah S. Long
1.
2.
2.1.
2.2.
2.3.
3.
3.1.
and Cervical Adenopathy
3.1.1.
3.1.2.
3.1.3.
3.2.
3.2.1.
3.2.2.
3.2.3.
3.2.4.
3.3.
3.3.1.
3.3.2.
3.3.3.
3.3.4.
3.4.
3.4.1.
3.4.2.
3.4.3.
3.4.4.
3.5.
3.5.1.
3.5.2.
3.5.3.
3.5.4.
4.
References
8.
Stephen Sze Shing Teo and
1.
2.
Contents xiii
2.1.
3.
3.1.
3.2.
4.
4.1.
4.1.1.
4.1.2.
4.2.
4.2.1.
4.2.2.
4.3.
4.4.
4.5.
4.5.1.
4.5.2.
4.5.3.
4.5.4.
4.5.5.
5.
5.1.
5.2.
5.3.
5.3.1.
5.3.2.
6.
6.1.
6.1.1.
6.1.2.
6.1.3.
and
6.2.
6.3.
6.4.
6.4.1.
6.4.2.
6.4.3.
7.
8.
References
9.
Peter J.
Loukas,
1.
2.
3.
4.
Promise for Developing Anthelminthic Vaccines
Contents
4.1.
4.2.
5.
Acknowledgments
References
10.
David A. Warrell
1.
2.
2.1.
2.2.
2.3.
globulin against EBLV?
2.4.
the United Kingdom?
3.
4.
5.
6.
7.
8.
8.1.
8.2.
8.3.
9.
10.
References
11.
Myron M.
1.
2.
3.
3.1.
3.2.
Chronic Typhoid Carriers
3.3.
3.3.1.
3.3.2.
3.3.3. Vi
3.4.
3.5. Vi
4.
References
Contents xv
12. Dexamethasone in
Bacterial Meningitis in Developing Countries:
Is it Beneficial?
Elizabeth Molyneux
1
2.
3.
4.
4.1.
5.
in Developing Countries
5.1.
5.1.1.
6.
7.
8.
and Placebo Group?
9.
References
13.
Therapy of Bacterial Meningitis in
Industrialised Countries?
Peter Mclntyre
1.
2.
3.
3.1.
3.1.1.
3.1.2.
3.1.3.
3.2.
3.2.1.
3.2.2.
3.2.3.
3.3.
3.3.1.
3.2.2.
3.4.
Sydney
3.4.1.
3.4.2.
4.
5.
References
xvi
14.
Tom Connell and Nigel Curtis
1.
2.
2.1.
2.2.
2.3.
2.4.
2.5.
3.
4.
4.1.
4.2.
5.
6.
6.1.
6.2.
6.3.
7.
7.1.
7.2.
7.3.
Acknowledgments
References
15.
Serogroup
Dominic F. Kelly and Rino Rappuoli
Abstract
1.
2.
3.
4.
References
Index
|
| adam_txt |
Contents
Contributing Authors
1.
Necrotizing Encephalopathy
Sarah S. Long
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
4.5.
References
2.
Sophie Hambleton and Ann M. An/in
1.
2.
3.
3.1.
3.2.
3.3.
3.3.1.
3.3.2.
3.3.3.
4.
4.1.
4.2.
4.3.
5.
References
3.
Upton D. Allen
1.
2.
Contents
2.1.
2.2. Model
3. EBV-Related
3.1.
3.2.
3.3.
3.4.
4.
4.1. Serologie
4.2.
5.
5.1.
5.1.1.
5.1.2.
5.1.3.
5.1.4.
• 5.2.
5.3.
5.3.1.
5.3.2.
6.
6.1.
6.2.
6.3.
6.4.
6.5.
7.
References
4.
Tract Infection
Caroline
1.
2.
2.1.
2.1.1.
2.1.2.
2.2.
2.2.1.
2.2.2.
2.3.
2.3.1.
2.3.2.
2.4.
2.5.
2.6.
2.7.
3.
3.1.
Contents xi
3.2.
3.3.
3.4.
4.
4.1.
4.2.
5.
5.1.
5.2.
6.
6.1.
6.2.
6.3.
6.4.
References
5.
to Clinical Presentation
Johan Bylund,
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
and Resolution of Inflammation
5.
5.1.
5.2.
5.3.
5.4.
References
6.
Capucine
1.
2.
2.1.
2.2.
2.3.
2.4.
2.5. IL-12Rßl
2.6.
2.7.
2.8.
x¡¡
3.
3.1.
3.2.
3.3.
4.
Acknowledgments
References
7.
Sarah S. Long
1.
2.
2.1.
2.2.
2.3.
3.
3.1.
and Cervical Adenopathy
3.1.1.
3.1.2.
3.1.3.
3.2.
3.2.1.
3.2.2.
3.2.3.
3.2.4.
3.3.
3.3.1.
3.3.2.
3.3.3.
3.3.4.
3.4.
3.4.1.
3.4.2.
3.4.3.
3.4.4.
3.5.
3.5.1.
3.5.2.
3.5.3.
3.5.4.
4.
References
8.
Stephen Sze Shing Teo and
1.
2.
Contents xiii
2.1.
3.
3.1.
3.2.
4.
4.1.
4.1.1.
4.1.2.
4.2.
4.2.1.
4.2.2.
4.3.
4.4.
4.5.
4.5.1.
4.5.2.
4.5.3.
4.5.4.
4.5.5.
5.
5.1.
5.2.
5.3.
5.3.1.
5.3.2.
6.
6.1.
6.1.1.
6.1.2.
6.1.3.
and
6.2.
6.3.
6.4.
6.4.1.
6.4.2.
6.4.3.
7.
8.
References
9.
Peter J.
Loukas,
1.
2.
3.
4.
Promise for Developing Anthelminthic Vaccines
Contents
4.1.
4.2.
5.
Acknowledgments
References
10.
David A. Warrell
1.
2.
2.1.
2.2.
2.3.
globulin against EBLV?
2.4.
the United Kingdom?
3.
4.
5.
6.
7.
8.
8.1.
8.2.
8.3.
9.
10.
References
11.
Myron M.
1.
2.
3.
3.1.
3.2.
Chronic Typhoid Carriers
3.3.
3.3.1.
3.3.2.
3.3.3. Vi
3.4.
3.5. Vi
4.
References
Contents xv
12. Dexamethasone in
Bacterial Meningitis in Developing Countries:
Is it Beneficial?
Elizabeth Molyneux
1
2.
3.
4.
4.1.
5.
in Developing Countries
5.1.
5.1.1.
6.
7.
8.
and Placebo Group?
9.
References
13.
Therapy of Bacterial Meningitis in
Industrialised Countries?
Peter Mclntyre
1.
2.
3.
3.1.
3.1.1.
3.1.2.
3.1.3.
3.2.
3.2.1.
3.2.2.
3.2.3.
3.3.
3.3.1.
3.2.2.
3.4.
Sydney
3.4.1.
3.4.2.
4.
5.
References
xvi
14.
Tom Connell and Nigel Curtis
1.
2.
2.1.
2.2.
2.3.
2.4.
2.5.
3.
4.
4.1.
4.2.
5.
6.
6.1.
6.2.
6.3.
7.
7.1.
7.2.
7.3.
Acknowledgments
References
15.
Serogroup
Dominic F. Kelly and Rino Rappuoli
Abstract
1.
2.
3.
4.
References
Index
Contents
Contributing Authors
1.
Necrotizing Encephalopathy
Sarah S. Long
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
4.5.
References
2.
Sophie Hambleton and Ann M. An/in
1.
2.
3.
3.1.
3.2.
3.3.
3.3.1.
3.3.2.
3.3.3.
4.
4.1.
4.2.
4.3.
5.
References
3.
Upton D. Allen
1.
2.
Contents
2.1.
2.2. Model
3. EBV-Related
3.1.
3.2.
3.3.
3.4.
4.
4.1. Serologie
4.2.
5.
5.1.
5.1.1.
5.1.2.
5.1.3.
5.1.4.
• 5.2.
5.3.
5.3.1.
5.3.2.
6.
6.1.
6.2.
6.3.
6.4.
6.5.
7.
References
4.
Tract Infection
Caroline
1.
2.
2.1.
2.1.1.
2.1.2.
2.2.
2.2.1.
2.2.2.
2.3.
2.3.1.
2.3.2.
2.4.
2.5.
2.6.
2.7.
3.
3.1.
Contents xi
3.2.
3.3.
3.4.
4.
4.1.
4.2.
5.
5.1.
5.2.
6.
6.1.
6.2.
6.3.
6.4.
References
5.
to Clinical Presentation
Johan Bylund,
1.
2.
3.
4.
4.1.
4.2.
4.3.
4.4.
and Resolution of Inflammation
5.
5.1.
5.2.
5.3.
5.4.
References
6.
Capucine
1.
2.
2.1.
2.2.
2.3.
2.4.
2.5. IL-12Rßl
2.6.
2.7.
2.8.
x¡¡
3.
3.1.
3.2.
3.3.
4.
Acknowledgments
References
7.
Sarah S. Long
1.
2.
2.1.
2.2.
2.3.
3.
3.1.
and Cervical Adenopathy
3.1.1.
3.1.2.
3.1.3.
3.2.
3.2.1.
3.2.2.
3.2.3.
3.2.4.
3.3.
3.3.1.
3.3.2.
3.3.3.
3.3.4.
3.4.
3.4.1.
3.4.2.
3.4.3.
3.4.4.
3.5.
3.5.1.
3.5.2.
3.5.3.
3.5.4.
4.
References
8.
Stephen Sze Shing Teo and
1.
2.
Contents xiii
2.1.
3.
3.1.
3.2.
4.
4.1.
4.1.1.
4.1.2.
4.2.
4.2.1.
4.2.2.
4.3.
4.4.
4.5.
4.5.1.
4.5.2.
4.5.3.
4.5.4.
4.5.5.
5.
5.1.
5.2.
5.3.
5.3.1.
5.3.2.
6.
6.1.
6.1.1.
6.1.2.
6.1.3.
and
6.2.
6.3.
6.4.
6.4.1.
6.4.2.
6.4.3.
7.
8.
References
9.
Peter J.
Loukas,
1.
2.
3.
4.
Promise for Developing Anthelminthic Vaccines
Contents
4.1.
4.2.
5.
Acknowledgments
References
10.
David A. Warrell
1.
2.
2.1.
2.2.
2.3.
globulin against EBLV?
2.4.
the United Kingdom?
3.
4.
5.
6.
7.
8.
8.1.
8.2.
8.3.
9.
10.
References
11.
Myron M.
1.
2.
3.
3.1.
3.2.
Chronic Typhoid Carriers
3.3.
3.3.1.
3.3.2.
3.3.3. Vi
3.4.
3.5. Vi
4.
References
Contents xv
12. Dexamethasone in
Bacterial Meningitis in Developing Countries:
Is it Beneficial?
Elizabeth Molyneux
1
2.
3.
4.
4.1.
5.
in Developing Countries
5.1.
5.1.1.
6.
7.
8.
and Placebo Group?
9.
References
13.
Therapy of Bacterial Meningitis in
Industrialised Countries?
Peter Mclntyre
1.
2.
3.
3.1.
3.1.1.
3.1.2.
3.1.3.
3.2.
3.2.1.
3.2.2.
3.2.3.
3.3.
3.3.1.
3.2.2.
3.4.
Sydney
3.4.1.
3.4.2.
4.
5.
References
xvi
14.
Tom Connell and Nigel Curtis
1.
2.
2.1.
2.2.
2.3.
2.4.
2.5.
3.
4.
4.1.
4.2.
5.
6.
6.1.
6.2.
6.3.
7.
7.1.
7.2.
7.3.
Acknowledgments
References
15.
Serogroup
Dominic F. Kelly and Rino Rappuoli
Abstract
1.
2.
3.
4.
References
Index |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| building | Verbundindex |
| bvnumber | BV020867060 |
| callnumber-first | R - Medicine |
| callnumber-label | RJ401 |
| callnumber-raw | RJ401 |
| callnumber-search | RJ401 |
| callnumber-sort | RJ 3401 |
| callnumber-subject | RJ - Pediatrics |
| classification_rvk | YD 1824 |
| ctrlnum | (OCoLC)318301146 (DE-599)BVBBV020867060 |
| dewey-full | 570 |
| dewey-hundreds | 500 - Natural sciences and mathematics |
| dewey-ones | 570 - Biology |
| dewey-raw | 570 |
| dewey-search | 570 |
| dewey-sort | 3570 |
| dewey-tens | 570 - Biology |
| discipline | Biologie Medizin |
| discipline_str_mv | Biologie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03025nam a2200649zcb4500</leader><controlfield tag="001">BV020867060</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20070328 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">051114s2005 xxuabd| |||| 10||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2005923474</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0387253416</subfield><subfield code="9">0-387-25341-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780387253411</subfield><subfield code="9">978-0-387-25341-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)318301146</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV020867060</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RJ401</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">570</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YD 1824</subfield><subfield code="0">(DE-625)153284:13153</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hot topics in infection and immunity in children II</subfield><subfield code="c">ed. by Andrew J. Pollard ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Springer</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIX, 234 S.</subfield><subfield code="b">Ill., graph. Darst., Kt.</subfield><subfield code="c">26 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Advances in experimental medicine and biology</subfield><subfield code="v">568</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Published in association with the British Paediatric Allergy, Immunity and Infection Group (BPAIIG), the European Society for Infectious Diseases (ESPID), and the Department of Paediatrics, University of Oxford. -- "This book is based on the course "Infection and Immunity in Children 2004" which was held at Keble College Oxford, UK in June 2004. This is the second book in this series covering topics in infection and immunity during childhood"--P. v.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Kind</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infection in children</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Children</subfield><subfield code="x">Diseases</subfield><subfield code="x">Immunological aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Communicable diseases in children</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infection</subfield><subfield code="x">drug therapy</subfield><subfield code="x">Child</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infection</subfield><subfield code="x">immunology</subfield><subfield code="x">Child</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bacterial Infections</subfield><subfield code="x">drug therapy</subfield><subfield code="x">Child</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bacterial Infections</subfield><subfield code="x">immunology</subfield><subfield code="x">Child</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Virus Diseases</subfield><subfield code="x">drug therapy</subfield><subfield code="x">Child</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Virus Diseases</subfield><subfield code="x">immunology</subfield><subfield code="x">Child</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Infektionskrankheit</subfield><subfield code="0">(DE-588)4026879-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antimikrobieller Wirkstoff</subfield><subfield code="0">(DE-588)4142688-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kind</subfield><subfield code="0">(DE-588)4030550-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Kind</subfield><subfield code="0">(DE-588)4030550-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Infektionskrankheit</subfield><subfield code="0">(DE-588)4026879-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Kind</subfield><subfield code="0">(DE-588)4030550-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Infektionskrankheit</subfield><subfield code="0">(DE-588)4026879-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Antimikrobieller Wirkstoff</subfield><subfield code="0">(DE-588)4142688-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pollard, Andrew J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Advances in experimental medicine and biology</subfield><subfield code="v">568</subfield><subfield code="w">(DE-604)BV000003102</subfield><subfield code="9">568</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014188871&sequence=000009&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-014188871</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Aufsatzsammlung Konferenzschrift |
| id | DE-604.BV020867060 |
| illustrated | Illustrated |
| index_date | 2024-07-02T13:24:43Z |
| indexdate | 2024-07-09T20:27:02Z |
| institution | BVB |
| isbn | 0387253416 9780387253411 |
| language | English |
| lccn | 2005923474 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-014188871 |
| oclc_num | 318301146 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR |
| owner_facet | DE-12 DE-355 DE-BY-UBR |
| physical | XIX, 234 S. Ill., graph. Darst., Kt. 26 cm |
| publishDate | 2005 |
| publishDateSearch | 2005 |
| publishDateSort | 2005 |
| publisher | Springer |
| record_format | marc |
| series | Advances in experimental medicine and biology |
| series2 | Advances in experimental medicine and biology |
| spelling | Hot topics in infection and immunity in children II ed. by Andrew J. Pollard ... New York, NY Springer 2005 XIX, 234 S. Ill., graph. Darst., Kt. 26 cm txt rdacontent n rdamedia nc rdacarrier Advances in experimental medicine and biology 568 Published in association with the British Paediatric Allergy, Immunity and Infection Group (BPAIIG), the European Society for Infectious Diseases (ESPID), and the Department of Paediatrics, University of Oxford. -- "This book is based on the course "Infection and Immunity in Children 2004" which was held at Keble College Oxford, UK in June 2004. This is the second book in this series covering topics in infection and immunity during childhood"--P. v. Includes bibliographical references and index Kind Infection in children Children Diseases Immunological aspects Communicable diseases in children Infection drug therapy Child Infection immunology Child Bacterial Infections drug therapy Child Bacterial Infections immunology Child Virus Diseases drug therapy Child Virus Diseases immunology Child Infektionskrankheit (DE-588)4026879-2 gnd rswk-swf Antimikrobieller Wirkstoff (DE-588)4142688-5 gnd rswk-swf Kind (DE-588)4030550-8 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content Kind (DE-588)4030550-8 s Infektionskrankheit (DE-588)4026879-2 s DE-604 Antimikrobieller Wirkstoff (DE-588)4142688-5 s b DE-604 Pollard, Andrew J. Sonstige oth Advances in experimental medicine and biology 568 (DE-604)BV000003102 568 Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014188871&sequence=000009&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Hot topics in infection and immunity in children II Advances in experimental medicine and biology Kind Infection in children Children Diseases Immunological aspects Communicable diseases in children Infection drug therapy Child Infection immunology Child Bacterial Infections drug therapy Child Bacterial Infections immunology Child Virus Diseases drug therapy Child Virus Diseases immunology Child Infektionskrankheit (DE-588)4026879-2 gnd Antimikrobieller Wirkstoff (DE-588)4142688-5 gnd Kind (DE-588)4030550-8 gnd |
| subject_GND | (DE-588)4026879-2 (DE-588)4142688-5 (DE-588)4030550-8 (DE-588)4143413-4 (DE-588)1071861417 |
| title | Hot topics in infection and immunity in children II |
| title_auth | Hot topics in infection and immunity in children II |
| title_exact_search | Hot topics in infection and immunity in children II |
| title_exact_search_txtP | Hot topics in infection and immunity in children II |
| title_full | Hot topics in infection and immunity in children II ed. by Andrew J. Pollard ... |
| title_fullStr | Hot topics in infection and immunity in children II ed. by Andrew J. Pollard ... |
| title_full_unstemmed | Hot topics in infection and immunity in children II ed. by Andrew J. Pollard ... |
| title_short | Hot topics in infection and immunity in children II |
| title_sort | hot topics in infection and immunity in children ii |
| topic | Kind Infection in children Children Diseases Immunological aspects Communicable diseases in children Infection drug therapy Child Infection immunology Child Bacterial Infections drug therapy Child Bacterial Infections immunology Child Virus Diseases drug therapy Child Virus Diseases immunology Child Infektionskrankheit (DE-588)4026879-2 gnd Antimikrobieller Wirkstoff (DE-588)4142688-5 gnd Kind (DE-588)4030550-8 gnd |
| topic_facet | Kind Infection in children Children Diseases Immunological aspects Communicable diseases in children Infection drug therapy Child Infection immunology Child Bacterial Infections drug therapy Child Bacterial Infections immunology Child Virus Diseases drug therapy Child Virus Diseases immunology Child Infektionskrankheit Antimikrobieller Wirkstoff Aufsatzsammlung Konferenzschrift |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014188871&sequence=000009&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000003102 |
| work_keys_str_mv | AT pollardandrewj hottopicsininfectionandimmunityinchildrenii |